HHS

U.S. Rep Steve Cohen (D-TN) has fired a shot across the bow of the Drug Enforcement Administration (DEA), demanding swift action on the ongoing review of marijuana's federal classification. In a letter he sent to DEA Administrator Anne Milgram, Cohen urged the agency to "move as swiftly as...

The Drug Enforcement Administration (DEA) told House lawmakers that the agency is “now conducting its review” of marijuana as a Schedule 1 drug, according to a letter obtained by Punchbowl News. What Happened: The fate of marijuana's federal classification hangs in the balance ...

The Health and Human Services Department (HHS) released more details regarding its recommendation to the DEA to reclassify cannabis to Schedule III under the federal Controlled Substances Act (CSA). On Thursday, attorneys Shane Pennington and Matt Zorn released 250...

Over the past several years, the US cannabis industry has experienced many important milestones. Among the important ones are the 24 states to date have legalized adult-use cannabis and some 40 states that have launched medical marijuana programs, President Biden’s pardon...

Two political coalitions, the left-leaning Marijuana Justice Coalition and the conservative Cannabis Freedom Alliance have united to urge President Joe Biden to fulfill his campaign promise by removing marijuana from the federal Controlled Substances Act (CSA). The coalition, which includes...

A coalition of 31 bipartisan House members sent a letter to DEA administrator Anne Milgram, urging the agency to consider congressional and state marijuana legalization efforts as it carries out its review into cannabis scheduling, which was recommended by President Biden nearly one year...

The Department of Health and Human Services disclosed a heavily redacted letter sent to the DEA concerning its recommendations for marijuana rescheduling. The exact contents of the message, including the actual scheduling recommendation and an attached scientific review, were withheld. The HHS...

Former DEA chiefs and retired White House drug czars are expressing concerns over the possible rescheduling of cannabis. In a letter addressed to U.S. Attorney General Merrick Garland and DEA administrator Anne Milgram, the 11 ex-officials argued that...

Congressional lawmakers from both sides of the aisle introduced a bicameral bill calling for further federal evaluation of kratom’s health and safety and prohibiting the Dept of Health and Human Services (HHS) from imposing more restrictive requirements on it than those for food or...

Attorney Matthew C. Zorn filed a complaint Friday in the U.S. District Court in Washington, D.C. against the Dept of Health and Human Services (HHS) demanding that it produce a requested copy of the letter issuing the cannabis scheduling review directive. What happened...

Senator Cynthia Lummis (R) and her colleague Senator Steve Daines (R), presented a bill to block cannabis legalization without congressional approval. What happened: On Thursday Lummis introduced the Deferring Executive Authority (DEA) Act, which aims to give Congress...

The American Council of Cannabis Medicine (ACCM) supports the Health and Human Services (HHS) recommendation to reclassify cannabis from a Schedule I to a Schedule III controlled substance. The ACCM said on Thursday that it has begun the DEA rescheduling application for cannabis, a step...

Tilray Brands (NASDAQ: TLRY) chairman and CEO Irwin D. Simon says his company is set to capitalize on possible cannabis legalization in the U.S. and anticipates creating beer infused with cannabis if/when it becomes legal. Simon has long been optimistic about legalization...

The case around the DEA's decision to terminate the employment of a special agent in 2020 after testing positive for THC is heating up, reported Marijuana Moment’s Kyle Jaeger. Anthony Armour, who served in the agency for 16 years as a special agent, sued the DEA in federal...

The announcement last week by the department of Health and Human Services (HHS) that it is now recommending the rescheduling of cannabis from schedule I to III, marks a significant inflection point for federal cannabis reform. The timing of the Drug Enforcement Agency (DEA...